---
title: "真正贴合临床的生信课题才更有意义"
date: 2024-03-31T23:43:27Z
draft: ["false"]
tags: [
  "fetched",
  "生信人"
]
categories: ["Acdemic"]
---
真正贴合临床的生信课题才更有意义 by 生信人
------
<div><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p>July</p></section></section></section><section><section powered-by="xiumi.us"><p><strong>概普生物 <span>2023</span></strong></p></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>NEW TOPIC</strong></p></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><strong>星标“生信人”精彩不错过</strong></p></section></section></section><section><section powered-by="xiumi.us"><section><img data-ratio="1.1363636363636365" data-src="https://mmbiz.qpic.cn/mmbiz_png/WpEKj19OcpKuGlT6OThKmJWlMbuQO5sogScOEEu7QXmFh7IKtwiba3XEGSqyvKcOIdnOT2WicjoAvvPeUGMpuSVA/640?wx_fmt=png" data-w="22" width="100%" src="https://mmbiz.qpic.cn/mmbiz_png/WpEKj19OcpKuGlT6OThKmJWlMbuQO5sogScOEEu7QXmFh7IKtwiba3XEGSqyvKcOIdnOT2WicjoAvvPeUGMpuSVA/640?wx_fmt=png"></section></section></section></section></section></section><p powered-by="xiumi.us"><br></p><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p>你是否听过这样一句话：“管它黑猫白猫，能捉老鼠的就是好猫”。关键之处在于能捉老鼠，如果“颜值”高一点，那就更受人喜爱了。但往往只有颜值也是会受人青睐的，为什么？因为现在老鼠不常见，而猫却很多。大家就开始卷颜值，就好比生信，发展到现在，结果图可以有各种各样的展现形式，实际解决临床问题的却很少。你要说生信只是一种工具，不错，它是一种工具不假，可再好的五金放在那，不被当作工具使用，依然和废铜烂铁无异。所以只有好好利用起来的五金“工具”，才是好猫。更直白一点，<span>只有真正贴合临床，致力于解决临床问题的生信分析，才是好课题，好文章</span>。</p><p><br></p><p>下面就从生信人团队做过的几个案例展开讲讲：</p></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><strong>1</strong></p></section></section></section><section><section powered-by="xiumi.us"><section><p><strong>临床问题+公开+测序数据+个性化生信分析</strong></p></section></section></section><section><svg viewbox="0 0 1 1"></svg></section></section><section powered-by="xiumi.us"><section><img data-ratio="0.16425992779783394" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyKhJMmDI2W44MWkG7I0S3SxRd1s76tjZT0SXDEcdWIacQZRHMFOKbJA/640?wx_fmt=png" data-w="554" width="100%" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyKhJMmDI2W44MWkG7I0S3SxRd1s76tjZT0SXDEcdWIacQZRHMFOKbJA/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p>作者认为，现阶段仍没有发现一种经过验证的头颈鳞状细胞癌（HNSC）生物标志物，可用于预测总生存期和对免疫疗法的反应。文章通过加权基因共表达网络分析鉴定了HNSC中22个免疫核心因子，使用cox回归确定了3个免疫基因并且构建了HNSC免疫相关基因预后指数（IRGPI），IRGPI高得分组相对于低得分组有更好的生存预后，并且与DNA损伤修复通路相关，有更高的免疫细胞浸润且倾向于免疫治疗获益。</p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><section><img data-ratio="0.6592592592592592" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyxicVk2bHzuYGEqw6vaHkib5xF598vicJiad3gUDunUNXtB6Ar0y1lHXg7Q/640?wx_fmt=png" data-w="1080" width="100%" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyxicVk2bHzuYGEqw6vaHkib5xF598vicJiad3gUDunUNXtB6Ar0y1lHXg7Q/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><p>PMID: 33097495 DOI: 10.3389/fonc.2022.881953</p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p>那么这篇文章，临床问题是缺乏HNSC的生物标志物。通过生信分析，找到了3个免疫基因并构建了IRGPI，同时，可用于区分HNSC的预后、分子和免疫特征以及作为免疫检查点抑制剂治疗疗效预测因子。这就相当于做了一些锦上添花的事情，既解决了“临床问题”，又增加了“颜值”，所以能发到13分的Clinical Cancer Research上。</p></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><strong>2</strong></p></section></section></section><section><section powered-by="xiumi.us"><section><p><strong>临床问题+自测+公开+个性化生信分析</strong></p></section></section></section><section><svg viewbox="0 0 1 1"></svg></section></section><section powered-by="xiumi.us"><section><img data-ratio="0.19133574007220217" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyBljIicqt6GwQKbEeebBdZPkwFaSOy1d6ENbBialYbIO1w42Mu5huz3jA/640?wx_fmt=png" data-w="554" width="100%" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyBljIicqt6GwQKbEeebBdZPkwFaSOy1d6ENbBialYbIO1w42Mu5huz3jA/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p>选择性聚腺苷酸化（APA）是一种重要的转录后修饰，参与肿瘤发展，但APA在肿瘤免疫中的功能在很大程度上仍未知。文章深入分析了31种癌症类型的10303个样本中蛋白编码基因的3'UTR用途和肿瘤免疫反应，开发出免疫相关APA事件（Imm-APA）评分系统，用于描述癌症免疫相关途径中APA事件的调控情况。基于该系统，确定了与免疫细胞浸润和免疫检查点阻断（ICB）治疗相关的生物标志物密切相关的肿瘤特异性lmm-APA，进一步构建ICB相关Imm-APA评分模型以预测免疫疗法的疗效。</p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><section><img data-ratio="0.6666666666666666" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyLt2l1icuJptx7v0QyGVicxmsnWgicWoAj2ia5wZ554nfia8Jicz9lsy96BTw/640?wx_fmt=png" data-w="555" width="100%" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyLt2l1icuJptx7v0QyGVicxmsnWgicWoAj2ia5wZ554nfia8Jicz9lsy96BTw/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><p>PMID: 35930727 DOI: 10.1158/0008-5472.CAN-22-1417</p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p>同样，这篇文章从转录后修饰APA事件对于肿瘤免疫未知影响的临床问题出发，通过生信分析，构建与肿瘤进展和肿瘤免疫相关的Imm-APA评分模型，通过该模型突出APA事件作为潜在生物标记物在癌症免疫治疗中的临床应用。发到了13.312分的Cancer Research上。</p><p><br></p><p>当然你要说，我的目标是发个三到八分的文章就可以了，更简单，使用公共数据加一点实验验证轻松满足预期。</p><p><br></p><p>再来看下面这个案例：</p></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><strong>3</strong></p></section></section></section><section><section powered-by="xiumi.us"><section><p><strong>临床问题+细胞系自测+公共数据+实验验证</strong></p></section></section></section><section><svg viewbox="0 0 1 1"></svg></section></section><section powered-by="xiumi.us"><section><img data-ratio="0.24187725631768953" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEy85l6N26QuszUf98onvOMfGyibQ57ZicaibWQ0jscdlian0V6gehjN73Djw/640?wx_fmt=png" data-w="554" width="100%" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEy85l6N26QuszUf98onvOMfGyibQ57ZicaibWQ0jscdlian0V6gehjN73Djw/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p>肿瘤相关成纤维细胞（CAFs）在调节肿瘤转移和治疗反应中发挥多种作用。目前的临床指标无法准确评估疾病风险和放疗反应，强调了迫切需要更多的分子预后标志物。为了研究与放疗相关的CAF相关基因，并构建前列腺癌预后CAF相关基因特征，作者通过X射线从Mus-CAF中建立了放射耐药前列腺CAF细胞亚系，进行转录组测序，联合公共数据集，分别构建无生化复发生存（BCRFS）相关和无转移生存（MFS）相关的signature，都可以准确地预测前列腺癌患者的BCRFS和MFS。结合各种临床因素组成的列线图可以准确预测前列腺癌患者的2年、3年和5年生存时间。</p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><section><img data-ratio="0.6872727272727273" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEylLmYKP3t4Diapv7axF3XBbLtSCohXHHaDdUFmoDEHcMbTkpfEIibxe8g/640?wx_fmt=png" data-w="550" width="100%" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEylLmYKP3t4Diapv7axF3XBbLtSCohXHHaDdUFmoDEHcMbTkpfEIibxe8g/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><p>PMID: 36195908 DOI: 10.1186/s12967-022-03656-5</p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p>这就是找到了一个明确的临床问题：与放疗相关的CAF相关基因对前列腺癌预后的影响。作者是怎么做的呢？公共数据库没有符合要求的数据，那就自己建立细胞系，条件成熟时进行测序，辅以公共数据，进行基础的生信分析构建预后signature，再加一点实验，医学2区8分的文章这不就来了？</p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><section><img data-ratio="0.34296028880866425" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyJ9KngWaggdOj1b0TAVEmu7JhIVHDbLsvybSwcbWibztfvUDJyibhiaR2Q/640?wx_fmt=png" data-w="554" width="100%" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjV5iapX0bBjyqXoYdGPUBOEyJ9KngWaggdOj1b0TAVEmu7JhIVHDbLsvybSwcbWibztfvUDJyibhiaR2Q/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p>本着“打造新型科研服务模式”的宗旨，概普生物将临床问题、临床信息和高通量组学数据相结合，助力医学轻松科研！截止到目前，概普生物已经与超过300家医院及科研单位合作，提供技术支持及延伸服务。有着丰富的经验与积累，所以大家有任何生信分析的需求，找我们就对了！</p><p><br></p><section powered-by="xiumi.us"><p><span><strong>个性化生信分析</strong></span></p><p><span><strong>扫码咨询</strong></span></p></section><section powered-by="xiumi.us"><section><img data-ratio="1" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWyOSqn02Y276EUPDodv5Gv6mekZHlj3966jUd1ibh8fc0nq9dUhrGLN3esGW3Lcmlwkf6fdoyicwJQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="150" src="https://mmbiz.qpic.cn/mmbiz_jpg/N3X4LBoaQjWyOSqn02Y276EUPDodv5Gv6mekZHlj3966jUd1ibh8fc0nq9dUhrGLN3esGW3Lcmlwkf6fdoyicwJQ/640?wx_fmt=jpeg"></section></section><p><br></p></section></section></section><h1>  </h1><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><svg viewbox="0 0 1 1"></svg></section></section></section><section><section powered-by="xiumi.us"><p><strong>往期热点 </strong><span><strong><span>（点击标题跳转）</span></strong></span></p></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>01</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214528&amp;idx=2&amp;sn=0b81200f628c17669485151ade52925d&amp;chksm=8b5f55afbc28dcb9c93ff31400a893604301943ddfb50d6c8406eb8737bb6d9f6a7fb5f57c71&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214528&amp;idx=2&amp;sn=0b81200f628c17669485151ade52925d&amp;chksm=8b5f55afbc28dcb9c93ff31400a893604301943ddfb50d6c8406eb8737bb6d9f6a7fb5f57c71&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214528&amp;idx=2&amp;sn=0b81200f628c17669485151ade52925d&amp;chksm=8b5f55afbc28dcb9c93ff31400a893604301943ddfb50d6c8406eb8737bb6d9f6a7fb5f57c71&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>线粒体质量控制</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>02</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214712&amp;idx=1&amp;sn=09dd54fe9f077c3a25cfc3b7b40b339f&amp;chksm=8b5f5417bc28dd0158bffa8c928296428f31c897abba4b12daaeae05f655a47889dec37ff6ab&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214712&amp;idx=1&amp;sn=09dd54fe9f077c3a25cfc3b7b40b339f&amp;chksm=8b5f5417bc28dd0158bffa8c928296428f31c897abba4b12daaeae05f655a47889dec37ff6ab&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214712&amp;idx=1&amp;sn=09dd54fe9f077c3a25cfc3b7b40b339f&amp;chksm=8b5f5417bc28dd0158bffa8c928296428f31c897abba4b12daaeae05f655a47889dec37ff6ab&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>孟德尔随机化</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>03</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651213782&amp;idx=1&amp;sn=6fab7af7962d65694a35e3f52abf39e4&amp;chksm=8b5f48b9bc28c1afbd0ec13b9eae9d8e08bf1a3c852d72e4c0c6420394fa362b1678d1a818ec&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651213782&amp;idx=1&amp;sn=6fab7af7962d65694a35e3f52abf39e4&amp;chksm=8b5f48b9bc28c1afbd0ec13b9eae9d8e08bf1a3c852d72e4c0c6420394fa362b1678d1a818ec&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651213782&amp;idx=1&amp;sn=6fab7af7962d65694a35e3f52abf39e4&amp;chksm=8b5f48b9bc28c1afbd0ec13b9eae9d8e08bf1a3c852d72e4c0c6420394fa362b1678d1a818ec&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>成纤维细胞（CAFs）</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>04</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>单细胞空间转录组</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>05</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>肿瘤相关巨噬细胞（TAM）</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>06</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>细胞死亡</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>07</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>耐药</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><img data-ratio="1" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWyOSqn02Y276EUPDodv5Gv4icYibT6yh8g0pYS2OJEe6fMV0Fvef3Ol47SkvEE8cWgL3HGt1QiapQzQ/640?wx_fmt=png" data-type="png" data-w="692" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWyOSqn02Y276EUPDodv5Gv4icYibT6yh8g0pYS2OJEe6fMV0Fvef3Ol47SkvEE8cWgL3HGt1QiapQzQ/640?wx_fmt=png"></section></section><section powered-by="xiumi.us"><section><p>公众号改版，添加微信，</p><p>防止失联，仅用于文章分享</p></section></section></section></section><section powered-by="xiumi.us"><p><br></p></section><section powered-by="xiumi.us"><p><span>图文排版｜CY</span></p><p>文章转载请联系 | 15510012760（微信）</p><p>广告商务合作 | 18501253903（微信）</p></section><section powered-by="xiumi.us"><p><br></p></section></section></section><p powered-by="xiumi.us"><br></p></section><p><br></p></section><p><mp-style-type data-value="10000"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/8YDTgZ1ECHcwgiLrGppF9A",target="_blank" rel="noopener noreferrer">原文链接</a>
